Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study

Phase: PHASE1 | Sponsor: University of Wisconsin, Madison | Compound: Psilocybin

Status

planned

Institution

University of Wisconsin, Madison

Start date

2026-02-01

End date

2028-02-01

Registry ID

NCT07360301

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.